Will Negative-Beta Stocks Help Outperform the TSX?

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen returns of over 4% year to date, while the TSX has seen losses.

| More on:

Beta is a measure of risk; specifically, it’s how risky a stock is in relation to the market. A beta of more than one indicates a stock has larger swings than the market, and a beta of less than one indicates it has less volatile swings. A negative beta, however, suggests that the stock moves in the opposite direction of the index. Beta can change over time, and one financial website can calculate beta over a different period of time than another website. It can be a moving target, so it is important to understand why there might be fluctuations or differences in it.

Alimentation Couche Tard Inc. (TSX:ATD.B) has a beta of -0.36, and year-to-date returns have been down over 2%, while the TSX has returned a loss of 0.90%. If we look at a broader range, 12 months, then Couche Tard has a positive return of 1%, but it is still less than the almost 4% the TSX has brought in. We need to look at the five-year window before we see the stock outperform the TSX, with its return climbing to 277% compared to just 28% for the market.

In the short term, Couche Tard has not provided investors with much security over the TSX and has actually performed worse. In the long term, the stock’s performance has been due in large part to its successful sales and profit growth over the years, and during that time its beta may have looked much different.

Waste Connections Inc. (TSX:WCN)(NYSE:WCN) also has a negative beta of -0.14 listed for its stock. Year to date, this stock has been up over 15% and almost 25% in the past 12 months. In this case, the negative-beta stock has vastly outperformed the TSX. If we extend the outlook to five years, then the gap is even wider, with Waste Connections yielding a total return of over 185%.

Waste Connections is a winner in all time frames and could be a good stock to rely on outperform the TSX.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) lists a high negative beta of -0.81 and, year to date, has seen returns of just over 4%. However, in the past 12 months, the stock has been much worse than the TSX, losing over 30% in value. In the past five years, the stock has declined by over 50%. The only time frame Valeant has proven to beat the TSX is during the short term.

The problem with this analysis is that Valeant’s stock has seen a significant tumble due to its own doing and internal problems. The recent outperformance of the TSX may have had more to do with the stock reaching a bottom rather than having a tendency to go in the opposite direction of the market.

With the exception of Waste Connections, the stocks here have not proven to be more helpful in beating the TSX, especially in the short term. The one reason Waste Connections may be able to ignore the TSX’s overall impact is because the company is effectively recession-proof; the company’s services are needed regardless of whether the economy is doing well or not.

Should you invest $1,000 in National Bank of Canada right now?

Before you buy stock in National Bank of Canada, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and National Bank of Canada wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals. Alimentation Couche Tard is a recommendation of Stock Advisor Canada.

More on Dividend Stocks

a sign flashes global stock data
Dividend Stocks

Where I’d Invest $8,000 In the TSX Today

There's no shortage of great stocks on the TSX today. Here's a look at three options to consider adding to…

Read more »

Two seniors float in a pool.
Dividend Stocks

How I’d Turn $7,000 Into a Growing Income Stream for Retirement

Investors looking for a growing income stream for retirement will find these stocks must-buy options right now.

Read more »

Tractor spraying a field of wheat
Dividend Stocks

Top 2 Canadian Stocks to Buy for Long-Term Gains

Sometimes investors worry too much about the near term, which is what makes these two top value options.

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

How I’d Build a Monthly Dividend Portfolio With $7,000

Investors can start building a monthly dividend portfolio through dividend ETFs that pay out monthly.

Read more »

a person watches a downward arrow crash through the floor
Dividend Stocks

Is This Correction Your Chance? Buy Up These 4 Dividend Stocks on Sale

These four dividend stocks aren't only top choices for yield, but for safety as well.

Read more »

ways to boost income
Dividend Stocks

1 Dividend Stock Down 34% From 52-Week Highs to Buy for Lifetime Income

This dividend stock is likely to just do even better, especially amidst copper prices.

Read more »

Man data analyze
Dividend Stocks

1 Magnificent Consumer Stock Down 17% to Buy and Hold Forever

Alimentation Couche-Tard (TSX:ATD) stock might be one of the best bargains available on the stock market for long-term investors right…

Read more »

data analyze research
Dividend Stocks

This 6% Dividend Stock Hasn’t Missed a Payment in 3 Decades

This TSX stock has a solid track record of dividend payments and growth. Moreover, it offers a sustainable yield of…

Read more »